By Andrew Kim, Research Associate and Nicholas Grous, Associate Portfolio Manager Now that 3.2 billion players are spending $180 billion per year, the global...
In a surprising decision that could undermine the blockbuster sales expectations for Pfizer and GSK’s new respiratory syncytial virus vaccines, the Centers for Disease...